SalioGen Therapeutics hit via layoffs, as gene-editing biotechs proceed to combat
SalioGen Therapeutics, an organization that raised $135 million to expand a brand new gene-editing era, has instituted standard layoffs and is scaling again its ambitions, in line with an individual acquainted with